Prenatal Testing and Newborn Screening Market Revenue, Company Profile, Key Trend Analysis & Forecast, 2035
The global non-invasive prenatal testing and newborn screening market is likely be worth $8.2 billion by 2027, representing a CAGR of 15%.
Read More: https://www.rootsanalysis.com/reports/global-non-invasive-prenatal-testing-and-newborn-screening-market-2017/167.html
It has been estimated that close to 131 million babies are born each year across the globe. Of these, approximately 7.9 million are born with birth defects. In fact, more than 7,000 genetic disorders have been identified so far and the number is rising.Genetic testing solutions that enable early detection of genetic abnormalities in fetuses and newborns are important to ensure that the person does not face complications later in life. With the emergence of innovative diagnostic and screening techniques, several methods of genetic testing have become popular. These include carrier testing, preimplantation genetic diagnosis / screening (PGD / PGS), prenatal testing, paternity testing and newborn screening. Amongst these, prenatal testing (primarily Non-invasive prenatal testing (NIPT)) and newborn screening have gained relatively more traction in prenatal and neonatal care.
The global non-invasive prenatal testing and newborn screening market is likely be worth $8.2 billion by 2027, representing a CAGR of 15%.
Read More: https://www.rootsanalysis.com/reports/global-non-invasive-prenatal-testing-and-newborn-screening-market-2017/167.html
It has been estimated that close to 131 million babies are born each year across the globe. Of these, approximately 7.9 million are born with birth defects. In fact, more than 7,000 genetic disorders have been identified so far and the number is rising.Genetic testing solutions that enable early detection of genetic abnormalities in fetuses and newborns are important to ensure that the person does not face complications later in life. With the emergence of innovative diagnostic and screening techniques, several methods of genetic testing have become popular. These include carrier testing, preimplantation genetic diagnosis / screening (PGD / PGS), prenatal testing, paternity testing and newborn screening. Amongst these, prenatal testing (primarily Non-invasive prenatal testing (NIPT)) and newborn screening have gained relatively more traction in prenatal and neonatal care.
Prenatal Testing and Newborn Screening Market Revenue, Company Profile, Key Trend Analysis & Forecast, 2035
The global non-invasive prenatal testing and newborn screening market is likely be worth $8.2 billion by 2027, representing a CAGR of 15%.
Read More: https://www.rootsanalysis.com/reports/global-non-invasive-prenatal-testing-and-newborn-screening-market-2017/167.html
It has been estimated that close to 131 million babies are born each year across the globe. Of these, approximately 7.9 million are born with birth defects. In fact, more than 7,000 genetic disorders have been identified so far and the number is rising.Genetic testing solutions that enable early detection of genetic abnormalities in fetuses and newborns are important to ensure that the person does not face complications later in life. With the emergence of innovative diagnostic and screening techniques, several methods of genetic testing have become popular. These include carrier testing, preimplantation genetic diagnosis / screening (PGD / PGS), prenatal testing, paternity testing and newborn screening. Amongst these, prenatal testing (primarily Non-invasive prenatal testing (NIPT)) and newborn screening have gained relatively more traction in prenatal and neonatal care.
0 Comments
0 Shares